Fresenius SE & Co. KGaA
ISIN: DE0005785604 | Ticker: FRE | LEI: XDFJ0CYCOO1FXRFTQS51
Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment. With over 300,000 employees in more than 100 countries around the globe, and annual sales exceeding €35 billion, Fresenius is one of the world’s leading healthcare companies.
Year founded1912
Served areaWorldwide
Headcount311,269
HeadquartersElse-Kröner-Straße 1, 61352 Bad Homburg v. d. Höhe – Germany
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER ENG | ENG | ENG | ENG |
| Corporate Governance Report | ||||
| Company Presentation | ENG | ENG | ENG | |
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER ENG | GER ENG | ENG GER | ENG |
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER ENG | GER ENG | ENG GER | ENG |
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER ENG | GER ENG | ENG GER | ENG GER |
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER ENG | ENG GER | ||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | ||||
| Corporate Governance Report | ||||
| Company Presentation | ENG | |||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 03.04.23 | Sen, Michael | Board | Buy | 586,989.25 € |
| 03.04.23 | Hennicken, Sara | Board | Buy | 49,839.92 € |
| 18.11.22 | De Meo, Dr. Francesco | Board | Buy | 50,415.29 € |
| 29.08.22 | De Meo, Dr. Francesco | Board | Sell | 50,831.20 € |
| 05.08.22 | Sturm, Stephan | Board | Buy | 119,676.59 € |
| 05.08.22 | Sturm, Stephan | Board | Buy | 119,831.44 € |
| 05.08.22 | Schmitt, Martin | Board | Buy | 5,150.00 € |
| 10.06.22 | Kirsch, Wolfgang | Supervisory board | Other | 6,901.09 € |
| 10.06.22 | Sturm, Stephan | Board | Other | 54,089.64 € |
| 04.04.22 | Sen, Michael | Board | Buy | 265,094.19 € |
558,502,143
IPOJan. 31, 2011
Stock exchange(s)Frankfurt Stock Exchange